TrialFrontiers in endocrinology2024

Clinical efficacy and mechanism of the combination of autologous platelet-rich gel and recombinant human acidic fibroblast growth factor in the management of refractory diabetic foot.

Xia Sheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.